08:25 AM EST, 02/27/2025 (MT Newswires) -- Scholar Rock ( SRRK ) reported a net loss Thursday of $2.47 per diluted share for 2024, widening from a loss of $1.99 in 2023.

Analysts surveyed by FactSet expected a loss of $2.43.

The biopharmaceutical company said it did not record any revenue for the years ended Dec. 31, 2024. Analysts surveyed by FactSet did not expect any revenue.

Shares of Scholar Rock ( SRRK ) were up 4.3% in recent premarket activity.